ArticleScientific reports2019

Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis.

Isabelle C Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.